Dementia and aging populations—A global priority for contextualized research and health policy

1. Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M. World Alzheimer Report 2016: Improving healthcare for people living with dementia. Alzheimer’s Disease International 2016.

2. Wu Y-T, Fratiglioni L, Matthews FE, Lobo A, Breteler MMB, Skoog I, Brayne C. Dementia in western Europe: epidemiological evidence and implications for policy making. Lancet Neurology Volume 15, No. 1, p116–124, January 2016

3. Matthews FE, Stephan BCM, Robinson L, Jagger C, Barnes LE, Arthur A, Brayne C & & Cognitive Function and Ageing Studies (CFAS) Collaboration. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nature Communications 7, Article number: 11398 (2016)

4. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–90. 6375662

5. St George-Hyslop P, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet. 1992 Dec;2(4):330–4. doi: 10.1038/ng1292-330 1303289

6. Alzheimer's Disease Collaborative Group. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet. 1995 Oct;11(2):219–22. doi: 10.1038/ng1095-219 7550356

7. Rogaev E, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995 Aug 31;376(6543):775–8. doi: 10.1038/376775a0 7651536

8. Desikan RS et al. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score

9. Yokoyama JS et al. Fine-mapping of the human leukocyte antigen (HLA) locus as a risk factor for Alzheimer's disease: A Case-Control Study,

10. Lipnicki DM et al. Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethno-cultural groups and geographic regions: a collaborative cohort study.

11. Blacker D et al. APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts

12. Campion D et al. APP, PSEN1 and PSEN2 mutations in early-onset Alzheimer disease: A cross-sectional study of 170 families and 119 sporadic cases

13. Cornelis E et al. Early diagnosis of mild cognitive impairment and mild dementia through basic and instrumental activities of daily living: Development of a new evaluation tool

14. Possin KL et al. Development of an adaptive, personalized, and scalable dementia care program: early findings from the Care Ecosystem

15. Grinberg LT et al. Neuropathological diagnoses and clinical correlates in an older adults population: insights from a community-based series from Brazil

16. Ferri CP, Jacob KS. Dementia in low-income and middle-income countries: different realities mandate tailored solutions.

17. Pierce A., Kawas C. Dementia in the Oldest-Old: Beyond Alzheimer Disease. PLoS Med

18. Clare L et al. Potentially-modifiable Lifestyle Factors, Cognitive Reserve and Cognitive Function in Later Life: a Cross-sectional Study.

19. Gardner RC et al. Subjective and objective cognitive function among older adults with a history of traumatic brain injury: A population-based cohort study

20. Dekhtyar S et al. Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: A community-based cohort study.

21. Mondor L et al. Multimorbidity and healthcare utilization among home care clients with dementia in Ontario, Canada: A retrospective analysis of a population-based cohort

22. Hillman A, Latimer J. Cultural representations of dementia